Dr. Reddy's Laboratories

Dr. Reddy's Laboratories will achieve growth with future P/E climbing to 17.75x

SNKRRMGM

Invested

Community Contributor

Published

09 Aug 25

Updated

09 Aug 25

SNKRRMGM's Fair Value

₹1,506.00

16.2% undervalued

09 Aug

₹1,262.70

-8.7%

3.5%

Author's Valuation

₹1.5k

16.2% undervalued

SNKRRMGM's Fair Value

Narrative

Updates0

SNKRRMGM'sFair Value

₹1.5k

16.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

4.09%

Pharma revenue growth rate

0.57%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.73%

Calculation

₹128.25b

Earnings '30

17.76x

PE Ratio '30

₹2.28t

Market Cap '30

₹2.28t

Market Cap '30

830.59m

No. shares '30

₹2.74k

Share Price '30

₹2.74k Share Price '30

Discounted to 2025 @ 12.73% p.a.

₹1.51k

Fair Value '25